SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1060NIH is thinking about sponsoring Avastin vs Lucentis head-to-head studies. Not aDewDiligence_on_SI-7/14/2006
1059Regeneron Gossip: Sector Snap: Biotechnology Wednesday July 5, 4:06 pm ET By Dadr.praveen-7/6/2006
1058With the 4X higher dose and the slower clearing rate, less frequent regime (everMiljenko Zuanic-6/3/2006
1057Going through the results, the second option is more likely. I think it is a verdr.praveen-6/2/2006
1056Wonder if this will rule out quarterly dosing for trap? Or does it leave an openrkrw-6/2/2006
1055He thinks.....they may.....aventis said...I told you so.... Will see what will Miljenko Zuanic-6/1/2006
1054Great question. He thinks they _may_ be able to file from a phase II single agenrkrw-6/1/2006
105307/08 time frame for NDA still looks to me as speculation and nothing more. Do yMiljenko Zuanic-6/1/2006
1052The lucentis comparator is in amd. Program is free and clear of Sanofi. That wasrkrw-5/31/2006
1051Anyone here going to the annual meeting next Friday? It starts at 10:30 am at tBiotech Jim-5/31/2006
1050Regeneron Receives Fast-Track Designation for the IL-1 Trap in CIAS1-Associated dr.praveen-5/31/2006
1049regn is saying 07/08 for filing.... regeneron.comrkrw-5/31/2006
1048<<A lot of clinical newsflow coming.>> From where? PI combination Miljenko Zuanic-5/25/2006
1047Per Morgan Stanley conference a couple of weeks ago, they hope for phase II datarkrw-5/21/2006
1046last i recall it was expected to be going faster than initially thought with pIImopgcw-5/21/2006
1045Hi Tuck n Board, I went through their latest press release and found the followdr.praveen-5/20/2006
1044Considerable weakness following the most recent discussion here. Good news, buttuck-5/20/2006
1043Thanks for the info. Getting to the market first should also help.rkrw-5/4/2006
1042<i>One question for the board. Is regn at risk of having a pricing problemDewDiligence_on_SI-5/4/2006
1041Companies make mistakes. Lucky break for regn if it works out. One question forkrw-5/4/2006
1040<i>… planed PIII may (will) have Lucentis as control arm.</i> That DewDiligence_on_SI-5/4/2006
1039Those are excellent results at six weeks following a single treatment. Given thiDewDiligence_on_SI-5/4/2006
1038Neil mentioned in his presentation today that planed PIII may (will) have LucentMiljenko Zuanic-5/4/2006
1037Update on ARVO and AMD studies. I suggest reading the most recent SEC filing asBiotech Jim-5/1/2006
1036<deleted>nigel bates-4/19/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News